tiprankstipranks
Trending News
More News >
Almado, Inc. (JP:4932)
:4932
Japanese Market

Almado, Inc. (4932) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4932

Almado, Inc.

(4932)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
,
Neutral 68 (OpenAI - 5.2)
Rating:68Neutral
Price Target:
¥948.00
▼(-15.58% Downside)
Action:ReiteratedDate:10/25/25
Almado, Inc. has a solid financial foundation with strong revenue growth and stable margins, but increased leverage and negative cash flow are concerns. The technical indicators suggest a bearish trend, but the valuation is reasonable with a high dividend yield, offering income potential.
Positive Factors
Sustained Revenue Growth
A ~24% revenue growth rate indicates expanding product adoption and market penetration that is likely to persist over months. Sustained top-line expansion supports reinvestment in R&D, scale economies and distribution, improving the company’s ability to fund growth without relying solely on external capital.
Stable Gross and Operating Margins
Robust gross margins and stable EBIT/EBITDA margins point to durable cost control and pricing power in core products. Consistent operating profitability supports free cash flow generation potential and provides a buffer against input cost swings, underpinning long-term margin sustainability.
Healthy Equity Base and Strong ROE
A healthy equity ratio combined with strong ROE implies efficient use of shareholder capital and a solid capital structure. This provides resilience in downturns, supports strategic investments, and improves access to financing on reasonable terms, benefiting long-term financial flexibility.
Negative Factors
Rising Leverage
An increased debt-to-equity ratio raises fixed interest obligations and reduces financial flexibility. Over a multi-month horizon higher leverage magnifies downside risk if growth slows or margins compress, constraining the firm’s ability to invest, service debt, or respond to shocks without dilutive financing.
Declining Free Cash Flow / Weak Operating Cash
A meaningful drop to negative operating cash flow undermines internal funding for capex, working capital and debt repayment. If persistent, weak cash generation forces dependence on external funding or asset sales, limiting strategic options and increasing execution risk over the medium term.
Eroding Net Profit Margin
A declining net margin, even if modest, signals rising operating or non‑operating costs that can steadily erode returns if not addressed. Over months this trend can compress retained earnings and free cash flow, reducing the company’s capacity to invest in growth or deleverage without margin recovery.

Almado, Inc. (4932) vs. iShares MSCI Japan ETF (EWJ)

Almado, Inc. Business Overview & Revenue Model

Company DescriptionAlmado, Inc. engages in the planning, development, and sale of cosmetics and supplements in Japan. The company offers basic cosmetics, makeup cosmetics, supplements, and quasi-drugs under the TO-II, Ode, CELLULA, Type III, AMF, Almado La Dina, and other brands. It also operates online stores for its products. The company was incorporated in 2000 and is headquartered in Tokyo, Japan.

Almado, Inc. Financial Statement Overview

Summary
Almado, Inc. shows strong revenue growth and stable margins, but increased leverage and recent negative cash flow are concerns. The company has a solid equity position and potential for recovery if cash flow management improves.
Income Statement
85
Very Positive
Almado, Inc. has demonstrated strong revenue growth over the past years, with a notable increase from 2024 to 2025. The gross profit margin remains robust, indicating effective cost management. However, the net profit margin has slightly decreased, suggesting increased expenses or other cost pressures. EBIT and EBITDA margins are stable, reflecting consistent operational efficiency.
Balance Sheet
78
Positive
The company's debt-to-equity ratio has increased, indicating higher leverage, which could pose a risk if not managed properly. However, the equity ratio remains healthy, and return on equity is strong, suggesting effective use of shareholder funds. The increase in total assets and equity over time reflects a solid financial position.
Cash Flow
65
Positive
Almado, Inc. experienced a significant decline in free cash flow in 2025, primarily due to negative operating cash flow. This raises concerns about cash generation capabilities. However, the company has previously shown strong free cash flow growth, and the operating cash flow to net income ratio indicates potential for recovery if operational challenges are addressed.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue9.24B8.48B7.54B6.53B5.37B4.55B
Gross Profit6.50B5.89B5.06B4.33B3.30B2.78B
EBITDA697.09M978.24M976.55M847.45M852.31M548.27M
Net Income461.63M650.41M695.46M585.80M582.21M367.96M
Balance Sheet
Total Assets4.83B4.72B3.83B3.67B3.37B2.99B
Cash, Cash Equivalents and Short-Term Investments1.18B1.57B1.51B1.39B1.18B1.13B
Total Debt3.31B2.11B1.00B551.89M72.79M73.66M
Total Liabilities4.16B2.85B1.95B1.34B679.65M670.28M
Stockholders Equity669.08M1.87B1.88B2.33B2.69B2.32B
Cash Flow
Free Cash Flow0.00-243.98M837.29M711.75M0.00640.85M
Operating Cash Flow0.00-189.09M846.27M711.75M260.42M653.96M
Investing Cash Flow0.00-108.06M-1.58M-7.13M-9.72M-13.11M
Financing Cash Flow0.00354.84M-720.19M-492.02M-208.23M-50.84M

Almado, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1123.00
Price Trends
50DMA
1039.14
Negative
100DMA
1067.92
Negative
200DMA
1091.55
Negative
Market Momentum
MACD
-46.16
Negative
RSI
27.42
Positive
STOCH
8.47
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4932, the sentiment is Negative. The current price of 1123 is above the 20-day moving average (MA) of 905.35, above the 50-day MA of 1039.14, and above the 200-day MA of 1091.55, indicating a bearish trend. The MACD of -46.16 indicates Negative momentum. The RSI at 27.42 is Positive, neither overbought nor oversold. The STOCH value of 8.47 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4932.

Almado, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
¥19.16B33.880.91%13.12%27.53%
68
Neutral
¥8.80B4.415.92%22.86%-32.11%
63
Neutral
¥6.81B12.522.38%-0.79%
63
Neutral
¥7.98B-49.922.65%11.87%-31.02%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
¥5.67B-33.121.68%8.46%
52
Neutral
¥5.41B42.42-19.42%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4932
Almado, Inc.
870.00
-186.46
-17.65%
JP:4925
HABA Laboratories, Inc.
1,801.00
-19.87
-1.09%
JP:4926
C'BON COSMETICS Co., Ltd.
1,325.00
150.74
12.84%
JP:4933
I-ne CO., LTD.
1,077.00
-578.79
-34.96%
JP:4934
Premier Anti-Aging Co., Ltd.
620.00
-250.00
-28.74%
JP:4936
AXXZIA, Inc.
331.00
-137.03
-29.28%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 25, 2025